Cargando…

Pomalidomide increases immune surface marker expression and immune recognition of oncovirus-infected cells

Most chronic viruses evade T-cell and natural killer (NK) immunity through downregulation of immune surface markers. Previously we showed that Pomalidomide (Pom) increases surface expression of major histocompatibility complex class I (MHC-I) in Kaposi sarcoma-associated herpesvirus-infected latent...

Descripción completa

Detalles Bibliográficos
Autores principales:	Davis, David A., Shrestha, Prabha, Aisabor, Ashley I., Stream, Alexandra, Galli, Veronica, Pise-Masison, Cynthia A., Tagawa, Takanobu, Ziegelbauer, Joseph M., Franchini, Genoveffa, Yarchoan, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343774/ https://www.ncbi.nlm.nih.gov/pubmed/30713808 http://dx.doi.org/10.1080/2162402X.2018.1546544

Ejemplares similares

Pomalidomide restores immune recognition of primary effusion lymphoma through upregulation of ICAM-1 and B7-2
por: Shrestha, Prabha, et al.
Publicado: (2021)

Mechanism and therapeutic implications of pomalidomide-induced immune surface marker upregulation in EBV-positive lymphomas
por: Jaeger, Hannah K., et al.
Publicado: (2023)

Restoration of immune surface molecules in Kaposi sarcoma-associated herpes virus infected cells by lenalidomide and pomalidomide
por: Davis, David A., et al.
Publicado: (2017)

Hijacking Host Immunity by the Human T-Cell Leukemia Virus Type-1: Implications for Therapeutic and Preventive Vaccines
por: Pise-Masison, Cynthia A., et al.
Publicado: (2022)

Transient Viral Activation in Human T Cell Leukemia Virus Type 1-Infected Macaques Treated With Pomalidomide
por: Gutowska, Anna, et al.
Publicado: (2022)

p30 protein: a critical regulator of HTLV-1 viral latency and host immunity
por: Moles, Ramona, et al.
Publicado: (2019)

Role of HTLV-1 orf-I encoded proteins in viral transmission and persistence
por: Sarkis, Sarkis, et al.
Publicado: (2019)

Inhibition of Tunneling Nanotube (TNT) Formation and Human T-cell Leukemia Virus Type 1 (HTLV-1) Transmission by Cytarabine
por: Omsland, Maria, et al.
Publicado: (2018)

Role of regulatory proteins in HIV-1/HTLV-1 coinfection
por: Edwards, Dustin, et al.
Publicado: (2014)

The contribution of monocytes/macrophages to HTLV-1 infection and persistence
por: de Castro-Amarante, Maria Fernanda, et al.
Publicado: (2014)

Oncoviruses and Pathogenic MicroRNAs in Humans
por: Fujii, Yoichi Robertus
Publicado: (2009)

The Role of Deubiquitinases in Oncovirus and Host Interactions
por: Li, Yueshuo, et al.
Publicado: (2019)

Orf-I and Orf-II-Encoded Proteins in HTLV-1 Infection and Persistence
por: Edwards, Dustin, et al.
Publicado: (2011)

Role of HTLV-1 p30 during infection of monocytes and dendritic cells
por: Fenizia, Claudio, et al.
Publicado: (2014)

Detection of HTLV-1 replication and CD4+ proliferation in the humanized BLT mouse model
por: Pise-Masison, Cynthia A, et al.
Publicado: (2015)

HTLV-1 burden dependent on hijacking monocytes chemotaxis
por: Castro-Amarante, Maria F, et al.
Publicado: (2015)

Will our dreams ever come true: treatment options for patients with HAM/TSP in 10 years
por: Pise-Masison, Cynthia
Publicado: (2014)

Tax-mediated re-routing of the HTLV-1 p13 protein to nuclear speckles
por: Andresen, Vibeke, et al.
Publicado: (2011)

Immunotherapy and Gene Therapy for Oncoviruses Infections: A Review
por: de Almeida, Nathália Alves Araújo, et al.
Publicado: (2021)

Oncoviruses and melanomas: A retrospective study and literature review
por: Ciccarese, Giulia, et al.
Publicado: (2022)

The Molecular Interplay between Human Oncoviruses and Telomerase in Cancer Development
por: Tornesello, Maria Lina, et al.
Publicado: (2022)

Memories of John N. Brady: scientist, mentor and friend
por: Pise-Masison, Cynthia A, et al.
Publicado: (2009)

Transcriptional regulators of human oncoviruses: structural and functional implications for anticancer therapy
por: Nečasová, Ivona, et al.
Publicado: (2022)

CDK4/6 inhibitors sensitize gammaherpesvirus-infected tumor cells to T-cell killing by enhancing expression of immune surface molecules
por: Wu, Yiquan, et al.
Publicado: (2022)

Characterizing Expression and Regulation of Gamma-Herpesviral Circular RNAs
por: Tagawa, Takanobu, et al.
Publicado: (2021)

The effect of chemotherapeutics on cell-to-cell transport of HTLV-1 and the p8 protein through membrane nanotubes
por: Omsland, M, et al.
Publicado: (2015)

Oncoviruses Can Drive Cancer by Rewiring Signaling Pathways Through Interface Mimicry
por: Guven-Maiorov, Emine, et al.
Publicado: (2019)

HIV-1-Mediated Acceleration of Oncovirus-Related Non-AIDS-Defining Cancers
por: Proulx, Jessica, et al.
Publicado: (2022)

Tumor-promoting myeloid cells in the pathogenesis of human oncoviruses: potential targets for immunotherapy
por: Aghamajidi, Azin, et al.
Publicado: (2022)

The reverse genetics of HTLV-1 infected patients
por: Alcantara, Luiz C, et al.
Publicado: (2011)

Use of pembrolizumab with or without pomalidomide in HIV-associated non-Hodgkin’s lymphoma
por: Lurain, Kathryn, et al.
Publicado: (2021)

Human Oncoviruses and p53 Tumor Suppressor Pathway Deregulation at the Origin of Human Cancers
por: Tornesello, Maria Lina, et al.
Publicado: (2018)

Polyploid Giant Cancer Cells, a Hallmark of Oncoviruses and a New Therapeutic Challenge
por: Herbein, Georges, et al.
Publicado: (2020)

HTLV-1 p12 modulates the levels of prion protein (PrP(C)) in CD4(+) T cells
por: Silva De Castro, Isabela, et al.
Publicado: (2023)

Population Pharmacokinetics of Pomalidomide
por: Li, Yan, et al.
Publicado: (2015)

Pomalidomide-induced hypothyroidism
por: Ali, Sulaiman Haji, et al.
Publicado: (2017)

Both orf-I isoforms, p12 and p8, are required for efficient HTLV-1 infection and persistence
por: Pise-Masison, Cynthia, et al.
Publicado: (2014)

Transcriptomic analyses reveal that the cellular Gem protein promotes HTLV-1 infected cell migration and viral transmission
por: Chevalier, Sébastien A, et al.
Publicado: (2014)

Contribution of Epstein–Barr Virus Lytic Proteins to Cancer Hallmarks and Implications from Other Oncoviruses
por: Dorothea, Mike, et al.
Publicado: (2023)

Engineered small extracellular vesicles as a novel platform to suppress human oncovirus-associated cancers
por: Owliaee, Iman, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_t4acnnhdcl6unkkgkbel979at4